Bentham Science Logo

Contents

Current Pharmaceutical Design, Volume 13 - Number 4

Editorial [Hot Topic: Recent Advances and Future Prospect in Protease Targeting (Executive Editor: B. Turk) ]

, 13(4): 347 - 348

Boris Turk


DOI: 10.2174/138161207780163015




Metallocarboxypeptidases: Emerging Drug Targets in Biomedicine

, 13(4): 349 - 366

Joan L. Arolas, Josep Vendrell, Francesc X. Aviles and Lloyd D. Fricker


DOI: 10.2174/138161207780162980




Inflammatory Caspases: Targets for Novel Therapies

, 13(4): 367 - 385

Sigrid Cornelis, Kristof Kersse, Nele Festjens, Mohamed Lamkanfi and Peter Vandenabeele


DOI: 10.2174/138161207780163006




Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets

, 13(4): 387 - 403

Olga Vasiljeva, Thomas Reinheckel, Christoph Peters, Dusan Turk, Vito Turk and Boris Turk


DOI: 10.2174/138161207780162962




Proteases Essential for Human Influenza Virus Entry into Cells and Their Inhibitors as Potential Therapeutic Agents

, 13(4): 405 - 414

Hiroshi Kido, Yuushi Okumura, Hiroshi Yamada, Trong Quang Le and Mihiro Yano


DOI: 10.2174/138161207780162971




Pharmaceutical and Biomedical Potential of PEGylated Dendrimers

, 13(4): 415 - 429

Virendra Gajbhiye, P. Vijayaraj Kumar, Rakesh Kumar Tekade and N. K. Jain


DOI: 10.2174/138161207780162999




Essentials of Daflon 500 mg: From Early Valve Protection to Long-Term Benefits in the Management of Chronic Venous Disease

, 13(4): 431 - 444

Luigi Pascarella


DOI: 10.2174/138161207780162953




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science